-
Dipyrone-NSAID Hybrids as CB2 Inverse Agonists Endowed with Analgesic Properties
Vol 2, 2022 -152409 -
Synthesis and ADME characterization of new sulfonylhydrazones designed as Rho kinase inhibitors for treatment of cardiovascular diseases
Vol 2, 2022 -152579 -
Synthesis and pharmacological evaluation of new dual inhibitors of HDAC6 and ROCK (2) as drug candidates for Alzheimer's Disease
Vol 2, 2022 -153223
Publications in other proceedings
-
XIV SO 2020
EVALUATION OF DUAL PI3K AND HDAC INHIBITION IN PROSTATE TUMOUR CELLS
-
43ª RASBQ
Síntese de Híbridos Dipirona-AINES, Planejados como Moduladores de Receptores Canabinoides
-
43ª RASBQ
Synthesis of newly substituted isoquinolinesulfonylhydrazones designed as Rho kinase inhibitors for treatment of heart failure and pulmonary hypertension
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
